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Chronic stress triggers activation of the sympathetic nervous system and drives malignancy. Using an immunodeficient
murine system, we showed that chronic stress–induced epinephrine promoted breast cancer stem-like properties via lactate
dehydrogenase A–dependent (LDHA-dependent) metabolic rewiring. Chronic stress–induced epinephrine activated LDHA
to generate lactate, and the adjusted pH directed USP28-mediated deubiquitination and stabilization of MYC. The SLUG
promoter was then activated by MYC, which promoted development of breast cancer stem-like traits. Using a drug screen that
targeted LDHA, we found that a chronic stress–induced cancer stem-like phenotype could be reversed by vitamin C. These
findings demonstrated the critical importance of psychological factors in promoting stem-like properties in breast cancer cells.
Thus, the LDHA-lowering agent vitamin C can be a potential approach for combating stress-associated breast cancer.

Introduction

Patients suffering from cancer often experience a variety of
chronic emotional stressors (1), including depression, anxiety,
and fear (2, 3). These serve as risk factors by facilitating tumor
growth and increasing expression of invasion-related genes that
promote cancer progression (4). Indeed, chronic stress increases
catecholamine levels and promotes tumor burden and invasive
growth of ovarian carcinoma cells in vivo (5). Moreover, stressinduced hormones have been shown to increase cancer cell dissemination in pancreatic cancer (4). Immune activity has long
been established as being suppressed by chronic stress and is
considered to be responsible for promoting cancer (6, 7). Yet,
the direct signaling network between stress pathways and a
cancer-propagating program remains almost completely unknown.
Cancer stem-like cells (CSCs) are characterized by an
increased capability of self-renewal (8) and tumor reconstitution
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(9). They are able to generate heterogeneous lineages of cancer
cells that constitute tumors. These CSCs are important for the initiation, maintenance, and clinical outcome of many cancers. Previous studies have demonstrated that transcription factors such
as MYC, SLUG, and SOX2 are responsible for tumorigenesis and
can reprogram cells from a differentiated to a stem-like state in a
variety of cancers (10–12). Indeed, the transcription factor MYC
plays key roles in oncogenesis and is involved in many cancer networks (13). MYC increases SOX2 transcriptional activity, forming a positive-feedback loop involving the Wnt/β-catenin/MYC/
SOX2 axis, which defines a highly tumorigenic cell subpopulation
in ALK-positive anaplastic large cell lymphomas (14). Moreover,
SOX2 represses microRNA-452 (miR-452), which acts as a metastasis suppressor to directly target the SLUG 3′-untranslated region
(3′-UTR). Taken together with miR-452 loss and SLUG upregulation, SOX2 provides a potentially novel mechanism by which
CSCs acquire metastatic potential (15).
Lactate dehydrogenase A (LDHA) executes the final step of
the Warburg effect by converting pyruvate to lactate. Moreover,
LDHA-associated lactic acid production leads to a relatively low
pH, allowing cancer cells to survive immune evasion via diminishing nuclear factor of activated T cells (NFAT) levels and T and NK
cell activation (16, 17). Deregulation of LDHA has been reported
in a number of malignancies, including prostate, breast, hepato-
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cellular, and gastrointestinal cancers (18–20). Inhibition of LDHA
reduces malignant transformation and delays tumor formation,
indicating an important role for LDHA in tumor initiation and progression (21). As might be predicted, LDHA consistently elevates
“stemness” properties of CSCs and enhances spheroid formation
in hepatocellular cancer (22). In this work, we define what to our
knowledge is a novel molecular pathway by which chronic stress
acts via β2-adrenergic receptor to elevate LDHA. This leads to a
switch to lactate production, and the adjusted pH then directs
USP28-mediated deubiquitination and stabilization of MYC,
thereby promoting stem-like traits in breast cancer. These data
provide what to our knowledge is a novel pathway that explains
how chronic stress promotes breast cancer progression by acting
directly on CSCs.

Results

Chronic stress promotes breast cancer stem-like traits via epinephrine-ADRB2. As described previously (5), we adapted an
accepted chronic stress model to nonobese diabetic–severe
combined immunodeficient (NOD/SCID) mice and examined
the effects of stress on both tumor growth and CSC self-renewal
ability (Supplemental Figure 1A; supplemental material available
online with this article; https://doi.org/10.1172/JCI121685DS1).
Beginning from 15 days after cancer cell implantation, tumors
from stressed mice were larger than those from control mice
(Figure 1A and Supplemental Figure 1B). Even though there was
no difference in body weight between the control and stressed
groups (Supplemental Figure 1C), tumors from the chronic stress
group continued to increase throughout the entire 30-day stress
paradigm. Subsequently, mice were subjected to behavioral
assays using both the tail suspension test and the open field test.
Chronically stressed mice exhibited more anxiogenic and depression-like behaviors than control mice (Supplemental Figure 1, D
and E). Consistently, C57BL/6 mice, the immunocompetent
mice, were injected with E0771 and Py8119 cells under stress.
The results indicated that stress enhanced the tumor burden in
the C57BL/6 mouse model (Supplemental Figure 1F).
After euthanasia in order to collect the xenografted tumors,
we found that stress-induced tumors expressed significantly higher levels of self-renewal genes. These included CTNNB, POU5F1,
and NANOG, as measured by both mRNA (Supplemental Figure
1G) and protein expression (Figure 1B and Supplemental Figure
1H). Similar results were also observed by immunohistochemical
analyses (Figure 1C and Supplemental Figure 1I). Next, single-cell
suspensions were prepared by enzymatic digestion from xenografts of both control and stressed mice. Mammosphere transplantation assays were used to assess their self-renewal abilities
in vitro. Tumor cells from the stressed group displayed greater
mammosphere-forming efficiencies in both the primary and secondary generations, as indicated by a significant increase in both
spheroid diameter and number (Figure 1D and Supplemental
Figure 1J). Stress significantly increased sphere formation frequencies of primary tumor cells as examined by in vitro limiting
dilution assays (Supplemental Figure 1K). In vivo, serially diluted
primary tumor cells were subcutaneously inoculated at 4 different
sites into each group of secondary mice (Supplemental Figure 1L).
Notably, tumor formation rates of stressed mice were increased.
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At the lowest number of implanted tumor cells (102), primary
stressed tumor cells increased tumor formation efficiency from
20% to 70% in secondary control mice, and enhanced tumor formation efficiency to 100% in secondary stressed mice (Table 1).
As expected, tumor formation in control and stressed mice did not
differ at the highest dose of tumor cells (105; 80% in control vs.
100% in stressed mice).
Immediately after the last day of stress, we collected blood
from all mice. Subsequently, we examined the serum concentration of the major adrenal stress hormones, including cortisol, norepinephrine, and epinephrine (23). Serum levels of epinephrine
displayed a sharp increase in the stress-induced group compared
with those with control treatment, whereas serum levels of cortisol did not differ significantly between groups (Figure 1E). We
then monitored xenograft growth in NOD/SCID mice injected
with epinephrine. We found that tumors from epinephrine-treated
mice were larger than those from PBS-treated mice, an effect that
occurred as soon as 15 days following tumor implantation (Supplemental Figure 2A). Both diameter and number of mammospheres
derived from the epinephrine-injected group were significantly
increased compared with those from PBS-treated control mice
(Supplemental Figure 2B). Consistently, epinephrine increased
the expression of self-renewal factors in a dose-dependent manner (Figure 1F). Norepinephrine marginally enhanced but cortisol
had no effect on the expression of self-renewal factors (Supplemental Figure 2, C and D).
Following injection of propranolol, an antagonist of adrenergic β-receptors (ADRBs), stressed mice demonstrated a significant decrease in tumor volume when compared with the
stress-only control group (Figure 1G). Notably, treatment with
propranolol caused a substantial reduction in tumor formation
efficiency and blocked stress-induced tumorigenesis (Tables 2
and 3). The potential role of ADRB1 or ADRB2 was then determined by silencing of ADRB1 and ADRB2 with small interfering
RNA (siRNA). This approach significantly blunted the stem-like
cell phenotype (Supplemental Figure 2, E and F). ADRB2 depletion efficiently blocked the epinephrine-induced enhancement
of breast CSCs (BCSCs) (Figure 1H and Supplemental Figure
2G), whereas ADRB1 knockdown did not (Supplemental Figure
2H). Similarly, the ADRB2 inhibitor ICI118,551 blocked the
epinephrine-increased β-catenin, OCT-4, and NANOG expression, whereas the ADRB1 inhibitor atenolol only had a marginal
effect (Supplemental Figure 2I). Further investigation demonstrated a similar reduction in tumor burden with the ADRB2
antagonist ICI118,551 (Figure 1I and Supplemental Figure 2J).
Following stress treatment for 5 weeks in the metastatic mouse
model, we found that stressed mice displayed more lung metastatic lesions as assessed by CT scans. Nodules on the surface of
lungs were counted, which revealed more nodules in the lungs of
stressed compared with control mice (Supplemental Figure 2K). In
contrast, shMYC- and shSLUG-mediated depletion reversed the
ability of stress to enhance lung metastasis. These data indicate
that chronic stress promotes the potential metastasis of cancer via
MYC and SLUG. Furthermore, epinephrine-treated cells showed
increased migration, invasion, and wound-healing abilities (Supplemental Figure 2, L and M). We also performed immunohistochemistry to examine changes in SNAIL1 and TWIST expression in
jci.org   Volume 129   Number 3   March 2019
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Figure 1. Chronic stress promotes ADRB2-dependent cancer stem cell–like properties in vivo. (A) Tumor growth of MDA-MB-231 tumors in control (Ctrl)
and stressed mice; n = 5 (1-way ANOVA). (B–D) Primary MDA-MB-231 tumors from the Ctrl and stress groups were subjected to immunoblot (C, control;
S, stressed) (B), immunohistochemical staining (scale bar: 50 μm; original magnification, ×20, ×40, ×96 [insets]) (C), and primary and secondary spheroid
formation; n = 5 (1-way ANOVA) (D). (E) Concentrations (pg/ml) of cortisol (Cort), norepinephrine (NE), and epinephrine (Epi) in serum of Ctrl and stress mice
after the last day of stress; n = 5 (Student’s t test). (F) Immunoblot analysis of indicated antibodies in MDA-MB-231 cells treated with indicated concentrations of Epi. (G) Growth of Ctrl, propranolol (Pro), stress, and stress-induced propranolol-treated (Pro + stress) MDA-MB-231 tumors in mice; n = 6 (1-way
ANOVA). (H) MDA-MB-231 cells were transfected with siADRB2 and then treated with Epi for 5 days. Expression of proteins was determined by immunoblot
analysis. (I) Growth of MDA-MB-231 tumors in Ctrl and stress mice in the presence or absence of ICI118,551 (ICI); n = 5 (1-way ANOVA). (J) Model of chronic
stress–mediated cancer stem-like traits mediated by β2-adrenergic receptor (ADRB2) signaling. Data are representative of at least 3 independent experiments. Data represent mean ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001.

stressed tumor tissues. The results indicated enhanced expression
of SNAIL1 and TWIST in stressed tumors compared with control
tumors (Supplemental Figure 2N). Collectively, these data demonstrate that chronic stress–induced epinephrine promotes breast
cancer stem-like properties by acting through ADRB2 (Figure 1J).
1032

jci.org   Volume 129   Number 3   March 2019

Chronic stress–induced MYC activates SLUG transcription to
stimulate CSCs. In order to investigate the downstream targets
responsible for the increase in stress-mediated stem-like properties in breast cancer, we used Affymetrix Human PrimeView
(analyzed from independent triplicates) to perform a large-scale
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Table 1. Serial dilution tumorigenesis
Inoculation

CtrlA

1 × 102
1 × 103
1 × 104
1 × 105

Ctrl
20%
40%
60%
80%
B

StressA
Ctrl
70%
70%
100%
100%
B

StressB
100%
100%
100%
100%

Statistical analysis for tumorigenesis with the cell numbers and
treatments indicated. APrimary treatment of mice; BSecondary treatment
of mice. n = 5.

expression profile analysis (Figure 2A). To further analyze the
functional importance of the altered gene sets (Table 4), we
performed Gene Ontology (GO) analysis including Biochemical Process, Cell Component, and Molecular Function, and
found that some important metabolic processes and cell migration were among the top 10 of GO analysis (Supplemental Figure 3A). Moreover, comparing the significantly altered genes in
microarray data with the Cancer Stem Cells Therapeutic Target
Database (24) and stem-like cell gene sets (8), we found that 4
stemness-associated genes displayed significantly altered
expression levels in epinephrine-induced tumors. Further verification of these genes in epinephrine-treated cells showed that
SLUG, a key regulatory factor in breast cancer stemness (25),
exhibited the greatest increase in cells following epinephrine
treatment (Figure 2B). Using 3 different inhibitory shRNAs, we
found that ablation of SLUG decreased expression of the stemness proteins β-catenin, OCT-4, and NANOG (Supplemental Figure 3B). Consistently, depletion of SLUG dramatically
reversed epinephrine-improved mammosphere formation ability (Figure 2C and Supplemental Figure 3C) as well as chronic
stress–induced tumor progression (Figure 2D). SLUG knockdown also inhibited the epinephrine-induced increased expression of β-catenin, OCT-4, and NANOG (Supplemental Figure
3D). These data suggest that SLUG plays a key role in the maintenance of stress-induced breast cancer stem-like properties.
To explore how SLUG mRNA is regulated, we evaluated the
half-life of SLUG mRNA in the presence and absence of epinephrine. We found that epinephrine had no significant effect on the
half-life of SLUG mRNA (Supplemental Figure 3E). Then, using
a luciferase reporter assay, we found that the SLUG promoter
(–2121 to 0 bp) is activated by epinephrine. Serial truncated analysis of the SLUG promoter (–1497 to 0, –997 to 0, –496 to 0 bp)
revealed that the –496 to 0 bp region of the SLUG promoter is
required for epinephrine-mediated SLUG transactivation (Figure
2E). Furthermore, by analysis of the SLUG promoter sequence
(–496 to 0 bp) using the JASPAR database (Supplemental Figure 3F), MYC was identified to be the most probable candidate
responsible for SLUG transactivation. As expected, overexpression or depletion of MYC remarkably increased and decreased,
respectively, both SLUG mRNA and SLUG protein expression
(Supplemental Figure 3, G and H). SLUG promoter activity was
dramatically enhanced or suppressed following up- or downregulation of MYC (Supplemental Figure 3I). In concordance with

these findings, activity of the truncated SLUG promoter (–496
to 0 bp) was enhanced upon epinephrine exposure, but it was
reversed upon MYC knockdown (Figure 2F).
To further define the binding sites of MYC in transactivating
SLUG, we constructed 3 MYC-responsive element mutants, –57/
–54 (Mut1, CGTG to TTTT), –104/–101 (Mut2, CACG to TTTT),
and –412/–408 (Mut3, CGTGG to TTTTT), and subcloned them
into a luciferase vector. Luciferase reporter assays showed that the
responsive element corresponding to Mut3 was responsible for
induction of MYC by epinephrine (Figure 2G and Supplemental
Figure 3J). We performed chromatin immunoprecipitation (ChIP)
assays using a MYC antibody and confirmed that MYC directly
binds to the –496 to –394 region of the endogenous SLUG promoter, whereas there was no binding in the –394 to 0 region of
the SLUG promoter (Figure 2H). These findings demonstrate that
MYC directly binds to the SLUG promoter and transactivates its
expression under epinephrine treatment (Figure 2I).
USP28 directly deubiquitinates and stabilizes MYC. To examine
the effects of chronic stress–induced epinephrine on MYC expression, we analyzed MYC mRNA and protein levels following epinephrine treatment for 5 days. Epinephrine led to a significant increase
in MYC protein (Figure 3A) but revealed no change in MYC mRNA
(Supplemental Figure 4A). We next treated cells with the protein
synthesis inhibitor cycloheximide to determine whether epinephrine regulates MYC protein degradation. Indeed, MYC protein levels
exhibited a gradual decrease in the absence of epinephrine, whereas
MYC degradation was significantly attenuated in the presence of
epinephrine (Figure 3B and Supplemental Figure 4B). These results
indicate that epinephrine enhances the stability of MYC protein.
As rapid MYC protein turnover can be mediated by the
ubiquitin-dependent proteasome pathway (26, 27), we treated
cells with the proteasome inhibitor MG132 in the presence of
epinephrine. Interestingly, MG132 enhanced MYC expression,
whereas epinephrine did not obviously increase MYC level under
MG132 treatment (Figure 3C), suggesting that epinephrine stabilizes MYC through inhibition of the proteasome-dependent
degradation pathway. We next coexpressed His-MYC and HAubiquitin in 293T cells, followed by treatment with epinephrine in
the presence or absence of MG132. MYC was heavily ubiquitinated in MG132-treated cells, but was significantly reduced following
epinephrine treatment (Supplemental Figure 4C). These results
suggest that epinephrine stabilizes MYC by eliminating its ubiquitination and consequent degradation.
MYC ubiquitination is a dynamic process involving ubiquitin
ligases and deubiquitinases (DUBs) (28). We identified the deubiquitinase USP28 as a key candidate that reverses epinephrineenhanced MYC expression by overexpressing E3 ligases or knockdown of DUBs (Figure 3D). As expected, depletion of USP28
remarkably decreased MYC protein and reversed epinephrine-induced increase in MYC protein expression (Supplemental Figure
4D and Figure 3E), whereas overexpression of USP28 enhanced
MYC expression (Supplemental Figure 4E). We further verified that
USP28 knockdown reduced epinephrine-induced MYC stabilization and directly bound to MYC box I through its USP domain without FBW7 (Figure 3F and Supplemental Figure 4, F–K).
To further investigate the functional impact of mutant USP28
(USP28Mut) in which the catalytic cysteine has been replaced by
jci.org   Volume 129   Number 3   March 2019
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Figure 2. Chronic stress–induced MYC activates SLUG transcription to stimulate CSCs. (A) A cluster heatmap of expression profiles of mRNAs in PBS- and
Epi-treated MDA-MB-231–derived tumors; n = 3. (B) Comparison of array data (fold change >2, Q < 0.05, 54 genes) with stem-like cell genes (405 genes).
Common genes were verified by Epi treatment and are listed in the column according to fold change. n = 3. (C) Distribution patterns and number (d > 50
μm) of mammospheres from the negative control (shNC) or shSLUG MDA-MB-231 cells after treatment with PBS or Epi for 5 days; n = 3 (1-way ANOVA).
(D) Growth of shNC or shSLUG-3 MDA-MB-231 tumors in mice with or without stress treatment; n = 6 (1-way ANOVA). (E) Dual-luciferase reporter assays of
MDA-MB-231 cells transfected with SLUG truncated promoters or empty vector (EV) in the presence or absence of Epi for 5 days; n = 3 (1-way ANOVA). (F)
Dual-luciferase analysis in shNC or shMYC MDA-MB-231 cells treated with PBS or Epi for 5 days and transfected with EV or SLUG promoter (–496 to 0);
n = 3 (1-way ANOVA). (G) Dual-luciferase reporter assays of MDA-MB-231 cells treated with Epi for 5 days and transfected with SLUG WT, mutant 1 (Mut1,
–57 to –54), mutant 2 (Mut2, –104 to –101), or mutant 3 (Mut3, –412 to –408) promoters; n = 3 (1-way ANOVA). (H) ChIP-PCR analysis in MDA-MB-231 cells
of MYC occupancy on the SLUG promoter. (I) Model of Epi-induced cancer stem-like traits through MYC/SLUG signaling. Data are representative of at least
3 independent experiments. Data represent mean ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001.

alanine (C171A), different models of binding between USP28WT
or USP28Mut and MYC46–74 amino acids were assessed using macromolecular modeling and molecular dynamics (MD) simulation
approaches (29). We obtained conformational free-energy surfaces
of USP28WT and USP28Mut with the MYC motif using fully atomistic
explicit-solvent force fields. This finding indicates a more favorable binding interaction between USP28WT and MYC than between
USP28Mut and MYC (Figure 3G).
1034
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This result is also confirmed by a distance diagram for the
USP28WT/Mut catalytic domain following MD simulation for 150
nanoseconds (Supplemental Figure 4, L–N). In addition, the
root-mean-square fluctuation profiles demonstrated greater
fluctuations in the USP28WT than in the mutant USP28Mut, a
finding that suggests more favorable binding of USP28WT to
the MYC46–74 motif (Supplemental Figure 4O). These results
explained how a single mutation in USP28 leads to a rather unfa-
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Figure 3. Chronic stress–induced USP28 stabilizes MYC and promotes CSCs. (A) Immunoblots of MYC in MDA-MB-231 and MCF-7 cells treated for 5 days
with PBS or Epi. (B) MDA-MB-231 cells were treated with Epi for 5 days followed by treatment with cycloheximide (CHX) for the indicated times. The intensity of MYC expression for each time point was quantified by densitometry and plotted against time. (C) Immunoblots of MDA-MB-231 cells treated with Epi
for 5 days and then incubated with or without MG132 for 6 hours. (D) Fold change of immunoblots of MDA-MB-231 cells transfected with indicated plasmids
followed by treatment with Epi for 5 days; n = 3 (Student’s t test). (E) Immunoblot analysis of MDA-MB-231 cells transfected with USP28 siRNA-2 followed
by treatment with PBS or Epi for 5 days. (F) Immunoprecipitation of USP28 constructs and MYC (amino acids 1–95) in 293T cells. (G) Free-energy surface of
the USP28WT-MYC46–74 complex and USP28Mut-MYC46–74 complex (top panel). Gray cartoons, USP28WT/Mut structures; red spheres, side chain of His600 and Cys/
Ala171; green cartoons, MYC motifs; blue spheres, Lys51 and Lys52 in MYC motif. (H) Ubiquitin assays of 293T cells transfected with MYC and WT or a C171A
mutant (Mut) of USP28 followed by treatment with Epi. (I) Distribution patterns and number (d > 50 μm) of mammospheres from cells in E; n = 3 (1-way
ANOVA). (J) Model of Epi-induced cancer stem-like traits through USP28/MYC/SLUG signaling. Data are representative of at least 3 independent experiments. Data represent mean ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001.

vorable binding between USP28Mut and MYC, indicating that the
Cys171 residue of USP28 is critical for binding MYC (Supplemental Videos 1 and 2). We then cotransfected USP28WT or USP28Mut
along with His-MYC and HA-ubiquitin into 293T cells. Ubiquitination assays showed that USP28Mut markedly increased
MYC ubiquitination level compared with USP28WT and reversed
the epinephrine-inhibited ubiquitin level of MYC (Figure 3H).
In agreement, USP28 knockdown decreased mammosphere
diameter and number (Figure 3I and Supplemental Figure 4P).
Together, these findings illustrate that epinephrine stabilizes
MYC protein by inducing USP28 and that USP28 Cys171 directly
interacts with the MYC MBI domain (Figure 3J).

Chronic stress recruits glycolytic activator LDHA to promote glucose metabolic rewiring. Metabolic reprogramming toward aerobic glycolysis and biomass accumulation is known to accompany
tumorigenesis (30). We therefore decided to study the role of glucose metabolism following chronic stress. Epinephrine-treated
cells increased glucose and lactate levels and decreased cellular
ATP compared with control cells (Figure 4A). Epinephrine-treated
cells exhibited an increased extracellular acidation rate and
decreased oxygen consumption rate (Supplemental Figure 5A).
Moreover, using targeted capillary electrophoresis–mass spectrometry (CE-MS), we extracted 54 metabolites and found a significant increase in the levels of glycolytic metabolites in epinephrinejci.org   Volume 129   Number 3   March 2019
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Figure 4. Chronic stress elevates LDHA to enhance glycolysis. (A) Glucose uptake, lactate production, and cellular ATP were measured in MCF-7 and MDAMB-231 cells treated with PBS or Epi for 5 days; n = 3 (Student’s t test). (B) Representative heatmap of metabolome profiles (top panel). Heatmap colors
represent relative metabolite levels as indicated in the color key. Average fold change of glycolytic metabolites was measured by capillary electrophoresis–
mass spectrometry (bottom). G-6-P, glucose-6-phosphate; F-6-P, fructose-6-phosphate; FBP, fructose-1,6-phosphate. n = 3 (Student’s t test). (C) Relative
mRNA expression of indicated genes in 4 GEO databases analyzed by GEO2R. (D) Immunoblot analysis of MDA-MB-231 cells treated with PBS or Epi for 5
days. (E) Immunoblot analysis of MDA-MB-231 and MCF-7 cells transfected with siLDHA in the presence or absence of Epi for 5 days. (F) Model of Epiinduced USP28/MYC signaling through LDHA-mediated metabolic rewiring. Data are representative of at least 3 independent experiments. Data represent
mean ± SEM; *P < 0.05, **P < 0.01.

treated compared with PBS-treated cells (Figure 4B and Supplemental Figure 5B). To further explore the differentially expressed
genes of glycolysis enzymes in CSCs, we analyzed 4 publicly accessible Gene Expression Omnibus (GEO) data sets of different cell
models with replicates. We discovered that glycolysis-associated
genes were enriched in a cancer stem cell population (Figure 4C).
These data suggest that epinephrine switches glucose metabolism
from homeostasis to glycolysis.
To examine the underlying cause for this switch, expression of
several key glycolytic enzymes following epinephrine treatment were
examined, including HK2, PFKM, PKM2, LDHA, and PDK1. We
observed that both HK2 and LDHA increased in response to epinephrine (Figure 4D and Supplemental Figure 5C). However, norepinephrine promoted the expression of PFKM and HK2, but not USP28,
MYC, or SLUG. In addition, cortisol had no effect on these key reg1036
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ulators (Supplemental Figure 5D). Also, high glucose consistently
triggered HK2 and LDHA expression and stimulated the USP28/
MYC axis in breast cancer cells (Supplemental Figure 5E). Silencing
of LDHA significantly reversed induction of USP28 and MYC by epinephrine (Figure 4E), while silencing of HK2 displayed no change on
the effect of epinephrine (Supplemental Figure 5F). Together, these
findings illustrate that epinephrine enhances USP28 expression via
induction of LDHA and metabolic rewiring (Figure 4F).
LDHA generating lactate enhances the USP28 signaling. To
examine the effects of chronic stress–induced epinephrine on
USP28 expression, we conducted quantitative PCR and found
that LDHA knockdown had no significant effect on USP28 mRNA
expression (Supplemental Figure 6A). To test the possibility that
LDHA affects USP28 stability, we treated cells with cycloheximide and found that the half-life of USP28 was shortened in LDHA-
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depleted cells (Figure 5A). Moreover, the reduction in expression
of USP28 caused by LDHA knockdown was reversed by MG132
(Figure 5B). LDHA ablation also rescued USP28 ubiquitination
that was inhibited by epinephrine (Figure 5C). Following treatment with the LDHA inhibitor sodium oxamate, we found a reduction in USP28 stabilization induced by LDHA in a dose-dependent
manner (Figure 5D and Supplemental Figure 6B).
To explore whether LDHA stabilizes USP28 expression
through its major product lactate, we treated cells with lactate and
found that it substantially increased USP28 protein (Figure 5E)
and prolonged the half-life of USP28 (Supplemental Figure 6C).
Importantly, USP28WT remarkably increased protein expression
of MYC, whereas USP28Mut reversed lactate-induced MYC and
SLUG (Figure 5F). Furthermore, we found that lactate enhanced
the interaction of MYC only with USP28WT. However, there was
no interactive effect when the USP28Mut was tested (Figure 5G and
Supplemental Figure 6D). Interestingly, the lactate-induced weak
acidic environment promoted USP28 signaling as well as hydrochloric acid and acetic acid (Figure 5H). Moreover, the pH 6.4 condition provides a closer distance between the MYC motif and the
USP28 catalytic domain than a neutral pH 7.4. This finding implicates a much more stable binding and more efficient deubiquitination in a weak acidic environment (Figure 5I, Supplemental Figure 6E, and Supplemental Video 3). In accord with these data, the
concentration of serum lactate was significantly higher in stressed
mice compared with control mice (Figure 5J). Collectively, these
data suggest that lactate enhances the USP28-MYC interaction via
generation of a local acidic microenvironment (Figure 5K).
High serum epinephrine is associated with poor prognosis and
activated LDHA/USP28/MYC/SLUG signaling axis in breast cancer patients. To evaluate the clinical relevance of circulating epinephrine, we studied the relationship between epinephrine and
clinical pathological parameters in 83 breast cancer patients
using serum samples and paraffin-embedded tissues, respectively. We first determined serum epinephrine concentrations
by ELISA and divided the patients into 2 groups, Epilo and Epihi,
based on receiver operating characteristic (ROC) curve analysis
(Supplemental Figure 7A). The relationship between serum epinephrine levels and clinical pathological parameters of breast
cancer patients were then analyzed (Table 5). High epinephrine
levels were not significantly correlated with tumor stage, node
stage, or other clinical pathological characteristics (HER2, ER,
and PR) (Table 5). Immunohistochemical staining was performed on these tissues, and the results revealed that high serum
epinephrine was positively associated with high LDHA, USP28,
MYC, and SLUG protein expression (Figure 6A and Supplemental Figure 7B). We next collected 5 pairs of breast cancer and
adjacent normal tissues and conducted Western blot analysis.
All breast cancer tissues displayed higher LDHA and USP28 protein levels when compared with adjacent normal tissues (Figure
6B and Supplemental Figure 7C). In addition, quantitative PCR
analysis showed that MDA-MB-231 sphere–enriched cells displayed higher LDHA-USP28-SLUG expression compared with
MDA-MB-231-2D cells (Figure 6C). These findings suggest that
high serum epinephrine is positively related to LDHA/USP28/
MYC/SLUG signaling and that LDHA can be a potential independent prognostic factor for breast cancer.

Patients with high serum epinephrine exhibited lower overall
survival (OS) rate and disease-free survival (DFS) rate compared
with patients with low epinephrine levels (Figure 6D). Meanwhile, Cox regression analysis showed that low serum epinephrine is a significant predictor of both longer OS and DFS (Table
6). We then divided 71 breast cancer samples into 2 groups,
LDHAlo and LDHAhi, by immunohistochemistry grade (data not
shown) based on the ROC curve analysis (Supplemental Figure
7D). As predicted, the LDHAhi group showed lower OS and DFS
rates compared with the LDHAlo group (Figure 6E). Notably, the
Epilo and LDHAlo groups displayed a more favorable prognosis
than the Epihi and LDHAhi groups, supporting the significant correlation between serum epinephrine levels and LDHA expression (Figure 6F).
Vitamin C is a promising intervention for breast cancer patients
with chronic stress. To identify a potential therapeutic agent for
patients undergoing chronic stress, we conducted a screen based
on the US drug collection of compounds. To this end, MDAMB-231 cells stably expressing the EGFP-LDHA fusion protein
were incubated with different compounds for 6 (1 μM or 2 μM)
or 12 hours (1 μM) (Figure 7A). The screening identified 18 compounds that lowered fluorescence of EGFP-LDHA, including vitamin C (Figure 7B and Supplemental Figure 8A). Virtual screening
of 2037 FDA-approved drugs against LDHA also revealed that
vitamin C was among the 7 vitamins in the top 200 hits (Supplemental Figure 8B). Furthermore, vitamin C has no effect on cell
viability at the experimental doses and time courses used (Supplemental Figure 8C). We next examined the impact of vitamin
C on epinephrine-induced LDHA/USP28/MYC/SLUG signaling
by Western blot analysis and found that vitamin C attenuated the
epinephrine-induced increase in LDHA, USP28, MYC, and SLUG
expression (Figure 7C).
The potential impact of vitamin C on LDHA activity was then
examined. We found that vitamin C suppressed lactate production
in both the absence and the presence of epinephrine (Figure 7D
and Supplemental Figure 8D). In addition, vitamin C significantly
caused a similar inhibition of BCSCs in the sphere formation assay
(Figure 7E). Next, we injected vitamin C to determine whether it
would inhibit tumor progression caused by chronic stress. Compared with the control stressed group, mice treated additionally
with vitamin C showed a significant reduction in tumor volume
(Figure 7F and Supplemental Figure 8E). We also generated an
MDA-MB-231 shLDHA cell line for tumor formation assays. Interestingly, knockdown of LDHA had an effect similar to that of vitamin C treatment, in which the stressed mice displayed an obvious
reduction in tumor volume compared with untreated controls
(Figure 7F). Taken together, these findings show that lowering of
LDHA by vitamin C reduces tumorigenicity and that vitamin C
might be a novel and effective therapeutic agent for targeting cancer in patients undergoing chronic stress (Figure 7G).

Discussion

Chronic stress is associated with aberrantly persistent activation
of the hypothalamic-pituitary-adrenal axis, leading to enhanced
production of cortisol and the simultaneous elevation of catecholamines (23). We find that chronic stress promotes tumor
progression in both immunocompetent and immunocomprojci.org   Volume 129   Number 3   March 2019
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Figure 5. LDHA generating lactate enhances the USP28 signaling. (A) Immunoblots of siNC and siLDHA MDA-MB-231 cells treated with CHX for the
indicated times. Intensity of USP28 expression for each time point was quantified by densitometry and plotted against time (right panel). (B) Immunoblots of MCF-7 cells treated for 5 days with Epi and/or siLDHA followed by incubation with or without MG132 for 6 hours. (C) Ubiquitin assays of 293T cells
transfected with ubiquitin (Ubi) and siLDHA followed by treatment with Epi. (D) Immunoblots of MDA-MB-231 cells treated with the indicated concentrations of sodium oxamate (Oxa) for 48 hours. (E) Immunoblots of MDA-MB-231 and MCF-7 cells treated with lactate (Lac) for 72 hours. (F) Immunoblots of
MDA-MB-231 cells transfected with USP28 WT or C171A and then treated with lactate for 72 hours. (G) Immunoblots of immunoprecipitation experiments
of 293T cells transfected with USP28 WT or C171A and then treated with lactate for 72 hours. (H) MDA-MB-231 cells were treated with lactate, hydrochloric
acid (HCl), and acetic acid (HAC) for 72 hours. Expression of the indicated proteins was examined by immunoblotting. (I) Snapshot structures of USP28
interacting with MYC motif extracted from constant-pH MD simulations at 2 representative pH conditions. Gray cartoons, USP28; green cartoons, MYC;
blue spheres, Lys51 and Lys52 on MYC motif; red spheres and yellow spheres, His600 and Cys171 of USP28, respectively. (J) Lactate levels in serum of Ctrl (n =
15) or stress (n = 20) mice (Student’s t test). (K) Model of chronic stress–mediated USP28 stabilization through decreased pH caused by LDHA generating
lactate. Data are representative of at least 3 independent experiments. Data represent mean ± SEM; ***P < 0.001.

mised mouse models. Furthermore, using a NOD/SCID mouse
model, we show that chronic stress increases epinephrine levels
and activates β2-adrenergic receptor to promote breast cancer
stem-like properties via metabolic rewiring. Chronic stress–
induced epinephrine enhances LDHA-dependent metabolic
activity, which increases lactate and augments USP28 that
serves to stabilize the MYC protein. The data further revealed
that MYC transactivates the SLUG promoter to enhance breast
1038
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cancer stem-like traits. In a drug screen that targeted LDHA,
we identified vitamin C as an agent capable of reversing the
chronic stress–induced cancer stem-like phenotype. These findings demonstrate the involvement of psychological factors in
promoting stem-like properties in breast cancer cells and promoting their tumorigenic potential. The mechanism is mediated
by an LDHA-mediated glycolysis-dependent pathway. Importantly, we suggest that vitamin C, which targets this pathway by
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Figure 6. Clinical relevance of LDHA expression under chronic stress. (A) Representative immunohistochemistry photomicrographs of tissues stained with
indicated antibodies in patients with breast cancer (Epilo, n = 42; and Epihi, n = 41). Scale bar: 50 μm; original magnification, ×20, ×40, ×96 (enlarged insets).
(B) Immunoblot analysis of proteins in breast cancer tissues (T) and adjacent normal breast tissues (N); n = 5. (C) Expression of mRNA for the indicated
genes in MDA-MB-231-2D cells or spheres was measured by quantitative reverse transcriptase PCR; n = 3 (Student’s t test). (D) Kaplan-Meier estimates of
overall survival and disease-free survival of patients with breast cancer, according to the serum Epi concentrations (Epilo, n = 42; and Epihi, n = 41). Eightythree patients were in the data set (log-rank test). (E) Kaplan-Meier estimates of overall survival and disease-free survival of patients with breast cancer,
according to LDHA expression (LDHAlo, n = 30; and LDHAhi, n = 41). Seventy-one patients were in the data set (log-rank test). (F) Kaplan-Meier estimates
of overall survival and disease-free survival of patients with breast cancer expressing high or low LDHA together with high or low serum Epi. Seventy-one
patients were in the data set (log-rank test). Data are representative of at least 3 independent experiments. Data represent mean ± SEM; ***P < 0.001.
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Figure 7. Vitamin C reverses chronic stress–induced breast cancer stem-like properties in vivo and in vitro. (A) US drug collection screening: MDA-MB-231
cells stably expressed with pEGFP-LDHA were treated with 1280 drugs. Fluorescence intensities were examined. n = 3. (B) Representative heatmap of
LDHA expression after treatment with the 18 candidate compounds; n = 3. Heatmap colors represent relative LDHA protein levels as indicated by the color
key. (C) Immunoblot analysis of MDA-MB-231 and MCF-7 cells treated with vitamin C and/or Epi for 5 days. (D) Lactate levels were examined in the cell
culture media of MDA-MB-231 cells in C; n = 3 (Student’s t test). (E) Representative spheroid images formed by single cells with vitamin C and/or Epi; n = 3.
Scale bar: 50 μm. Bottom left panel shows distribution patterns of sphere diameter. Bottom right panel shows the number of spheres (d > 50 μm) (1-way
ANOVA). (F) Tumor growth curves of indicated treatments of mice; n = 5 (1-way ANOVA). (G) Model of targeting chronic stress–mediated cancer stem-like
traits by vitamin C. Data are representative of at least 3 independent experiments. Data represent mean ± SEM; *P < 0.05, **P < 0.01.

inhibiting LDHA, is a potential treatment for the stress-associated increase in breast cancer.
A substantial body of literature describes the effect of chronic
stress on tumor progression. Stress-induced hormones control
a number of important biological processes, such as metabolic
events, immune activity, and apoptosis. Cortisol, a key stress hormone, improves the hypoglycemic profile by promoting gluconeogenesis (31) and endoplasmic glucose production via pyridine
nucleotide redox reactions (32). Similarly, another vital stress
1040
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hormone, epinephrine, stimulates glycogenolysis by activating
glycogen synthase and increasing insulin-stimulated glucose
uptake (33). In our experiments, epinephrine-treated cells consistently increased glucose and lactate levels and reduced cellular
ATP levels. Furthermore, chronic exposure to epinephrine promotes the establishment of immunosuppressive microenvironments through the induction of a COX2-dependent pathway (34).
Epinephrine can also enhance antiapoptotic functions through
cAMP-dependent phosphorylation of BAD (35). In addition,
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Table 2. Serial dilution tumorigenesis
Inoculation

CtrlA
Ctrl
20%
20%
60%
80%
B

1 × 102
1 × 103
1 × 104
1 × 105

Stress
40%
60%
80%
80%

StressA
Pro
20%
20%
60%
60%

B

B

Pro + stress
20%
40%
40%
60%

B

Ctrl
60%
80%
100%
100%
B

Stress
60%
100%
100%
100%

B

ProB
20%
40%
60%
60%

Pro + stressB
40%
60%
80%
80%

Serially diluted tumor cells from primary-treated mice (Ctrl and Stress) were subcutaneously inoculated at 4 different sites into each group of mice.
Statistical analysis of tumorigenesis with indicated cell numbers and different treatments is shown. APrimary treatment of mice; Bsecondary treatment of
mice. n = 5.

chronic stress facilitated tumor angiogenesis through β-adrenergic activation of the cAMP/PKA signaling pathway in vivo and
thereby promoted tumor growth (5). Stress-induced hormones,
especially norepinephrine and epinephrine, protected the ovarian tumor cells from anoikis and promoted their proliferation
by phosphorylating focal adhesion kinase (FAK) at Y397 in vitro
and in vivo (36). Consistently, we demonstrate that chronic stress
increases epinephrine levels to promote tumorigenesis and cancer
stem-like traits via activation of the LDHA/USP28/MYC/SLUG
signaling axis in a mouse model.
Our data showed that high epinephrine in patient serum was
positively associated with high LDHA, USP28, MYC, and SLUG
expression and conferred lower overall survival and disease-free
survival rates compared with those of patients with low epinephrine levels. In addition, epinephrine levels are not constant and
can be influenced by activities such as exercise. Tumor-bearing
mice with access to running wheels showed reduced growth of ERpositive breast tumors via activation of the Hippo signaling pathway, a known regulator of cancer stem cells (37). The exerciseinduced epinephrine surge and IL-6 suppress tumor growth and
development through NK cell mobilization and redistribution (38,
39). These studies reveal that high-intensity exercise markedly
upregulates epinephrine to an extremely high level, which may
lead to suppression of cancer. Hence, the comprehensive influence
on epinephrine levels should be carefully evaluated in the further
patient outcome and drug intervention. Our results also show that
norepinephrine but not cortisol moderately enhanced the expression of self-renewal regulators (NANOG, OCT-4, and β-catenin)
and glycolysis enzymes (PFKM and HK2). The mechanism by

which norepinephrine contributes to cancer stem-like properties
and glucose metabolism is worth exploring further.
The transcription factor SLUG is a member of the Snail family
that is essential for embryonic development (40, 41). Emerging evidence demonstrates that SLUG plays an essential role in metastasis
due to its endogenous overexpression in a variety of cancers (42, 43).
SLUG is also a key protein that controls cancer cell stemness (44).
Using Affymetrix Human PrimeView to perform large-scale expression profile analysis followed by comparison with the array data (fold
change >2, Q < 0.05) with a stem cell gene set, we found that SLUG
expression was significantly increased in mice treated with epinephrine. MYC activates a diverse group of genes that are known to promote cell growth and proliferation as part of a heterodimeric complex with the protein MAX. The MYC-MAX heterodimer is capable
of binding specific DNA sequences, such as the E-box sequence
CACGTG (45, 46). In our studies, analysis through the JASPAR database first confirmed that MYC activates SLUG transcription to stimulate CSCs. These results are consistent with the previous finding
that MYC binds directly to the SLUG DNA sequence –412 to –408 to
transactivate its expression in breast cancer.
An unbiased search screen has been reported for MYC, from
which we determined that the deubiquitinase USP28 directly stabilizes the MYC protein in our chronic stress system. USP28 is a
USP member of the DUB family, which has 4 known domains.
Previous studies have shown that USP28 does not bind to MYC
directly but rather binds MYC through interaction with FBW7 (47).
Emerging evidence demonstrates that USP28 can bind and promote deubiquitination of MYC in the absence of FBW7 in intestinal crypt stem cells (29). Importantly, our results establish that the

Table 3. Serial dilution tumorigenesis
Inoculation

ProA
Ctrl
20%
40%
60%
80%
B

1 × 10
1 × 103
1 × 104
1 × 105
2

Stress
40%
60%
80%
80%

B

Pro + stressA
Pro
0%
0%
20%
60%
B

Pro + stress
20%
40%
60%
80%

B

Ctrl
20%
20%
80%
100%
B

Stress
40%
40%
80%
100%

B

ProB
0%
20%
60%
80%

Pro + stressB
20%
40%
80%
100%

Serially diluted tumor cells from primary-treated mice (Pro and Pro + stress) were subcutaneously inoculated at 4 different sites into each group of mice.
Statistical analysis of tumorigenesis with indicated cell numbers and different treatments is shown. APrimary treatment of mice; Bsecondary treatment of
mice. n = 5.
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Table 4. Altered genes in microarray data
117 Altered genes in microarray data (fold change >2, P < 0.05)
ABCC2
AFAP1L1
ANXA8L1
ATP6V0A4
BMP4
COL5A1
DNMBP
ENPP1
FAM83A
GADD45A
HIST1H2BD
HMGB3
INSL4
KRTAP2-3
SYNE3
NRP1
PARD6B
PLOD2
RASGRP3
SLPI
STEAP1B
TMEM154
TRIO
WISP2

ABCC3
AHNAK2
ANXA8L2
B3GNT5
C15orf48
CORO2B
DUSP1
ENPP2
FHL1
GJB2
HIST1H2BK
HOXB3
ISG15
KRTAP2-4
LPAR1
OASL
PCDH7
PTGS2
RGCC
SLUG
SUSD2
TMEM158
TSPAN5
ZNF185

ABCG2
AKR1C1
ARG2
BANK1
CALB2
CREB5
DUSP5
EPSTI1
FOXQ1
GKN2
HK2
HS3ST1
ITGA2
LAMB3
NDRG1
OGFRL1
PDE2A
PTPRF
RGS17
SOX9
TFAP2C
TNC
TSPAN8

ABLIM3
AKR1C2
ARHGAP22
BCL2A1
CDCP1
CSGALNACT1
ECM1
F3
FRMD4A
GNG11
HMGA1
IER5L
JUN
LCP1
NQO1
OSBPL10
PITPNC1
PTX3
S100P
STC1
TGFBI
TNFAIP3
TXNIP

ADM
ANXA8
ASNS
BDNF
COL13A1
CYP1B1
EFEMP1
FAM129A
FRMD5
HIST1H2AC
HMGA2
IL7R
KRT81
LGALS8
NRG1
OTUB2
PLAT
RARRES3
SDC2
STEAP1
TMCC3
TNFRSF21
WHSC1

MYC MBI domain (1–95 amino acids) interacts directly with the
USP domain (160–652 amino acids) of USP28. Its crystal structure
showed that USP28 interacts with MYC through C171 and the MBI
domain. Moreover, recent findings show the ubiquitination sites of
MYC, including Lys 51, Lys 148, Lys 389, and Lys 430, in response
to DNA damage using quantitative proteomics (48). Our computational simulation analysis also revealed that USP28 displayed
possible binding to Lys 51 and Lys 52 of MYC, which implied that
ubiquitination might be involved in USP28’s binding to MYC.
Cancer cells show profound metabolic changes, mainly comprising aerobic glycolysis, de novo lipid biosynthesis, and glutamine-dependent anaplerosis, all of which provide energy and
building blocks to sustain their high proliferation rates (49). The
first noted change in cancer metabolism was in aerobic glycolysis,
known as the Warburg effect. It is characterized by the ATP generation pattern shifting from oxidative phosphorylation to glycolysis, even under normal oxygen concentrations (50). This effect
is regulated by PI3K, hypoxia-inducible factor (HIF), p53, MYC,
and AMP-activated protein kinase (AMPK)/liver kinase B1 (LKB1)
pathways (51). To analyze whether glycolysis is involved in the
effects of epinephrine on breast cancer cells, we used CE-MS to
examine changes in metabolites in stressed cells. This approach
revealed a significant enrichment in metabolic processes. In glycolysis, LDHA executes the final step of aerobic glycolysis signaling by converting pyruvate to lactate. Deregulation of LDHA has
been reported in many cancers (18–20, 52), but the underlying
biochemical process by which LDHA acts on cancer cells has been
1042
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unknown. Our results reveal that LDHA induces glucose metabolic disorders and stabilizes USP28 expression. However, the
detailed mechanism by which LDHA stabilizes USP28 expression
needs to be further explored.
The LDHA inhibitor sodium oxamate is known to be an effective anticancer agent in many types of cancer, including breast
(53–56), non–small cell lung (57), and gastric cancer (58). However, the clinical application of sodium oxamate has been limited
because of its high therapeutic doses and relatively low potency (59–61). As a result, new medications are urgently needed to
replace sodium oxamate for targeting LDHA and to reverse the
chronic stress–derived breast cancer stem-like phenotype. Using
an FDA-approved high-throughput drug screen that includes 1280
drugs, we identified vitamin C as one of 18 molecules that lowered
LDHA expression. Recent reports support our findings that vitamin C is an effective anticancer agent. For example, high levels
of vitamin C can selectively kill KRAS- and BRAF-driven colorectal cancer cells by inducing oxidative stress, suppressing glycolysis and the subsequent energy crisis (62). High-dose intravenous
vitamin C also promotes cell death through depletion of NAD+ and
inhibits motility and mitosis by increasing α-tubulin acetylation in
pancreatic cancer (63). In addition, physiological-level vitamin C,
acting as an antioxidant, increases the activity of TET enzymes to
rebuild 5-hydroxymethylcytosine (5hmC) content, leading to the
inhibition of invasiveness and clonogenic growth in melanoma
(64). Low-dose vitamin C as a cofactor of TET enhances the apoptosis effect of DNMT inhibitors via enhancing immune signals in
the treatment of hematological cancers (65). It is also noteworthy
that vitamin C–treated stressed mice display a significant reduction in depressive-like behaviors (66). Furthermore, vitamin C
specifically targets breast cancer stem cells via suppression of glycolysis due to loss of mitochondrial function (67). Vitamin C counteracts miR-302/367 to suppress breast cancer stem cell reprogramming via decreasing TET1 gene expression (68). Although
a recent study indicated that high-dose vitamin C selectively
induced DNA damage on glioblastoma stem cells rather than differentiated tumor cells, it also displayed the cellular toxicity on
neural stem and progenitor cells (69). In our study, vitamin C suppressed stress-induced LDHA, thus altering the lactate production
to inhibit the USP28/MYC/SLUG axis in breast cancer stem cells.

Methods

Cell lines and culture conditions. Human breast cancer cell lines (MDAMB-231 and MCF-7) and 293T were purchased from the American
Type Culture Collection (ATCC). These cell lines were authenticated
at ATCC before purchase by standard short tandem repeat DNA-typing methodology. The murine mammary carcinoma cell line E0771
was purchased from BeNa Culture Collection. The Py8119 cell line
was provided by Suling Liu (Fudan University, Shanghai, China). The
MDA-MB-231, E0771, and 293T cell lines were maintained in Dulbecco’s modified Eagle medium (DMEM; Invitrogen) supplemented with
10% FBS (Invitrogen Corp.). The MCF-7 cell line was maintained in
Eagle’s minimum essential medium (Invitrogen Corp.) supplemented
with 10% FBS and 0.01 mg/ml human recombinant insulin. The
Py8119 cell line was maintained in F12K nutrient media (HyClone)
supplemented with 5% FBS. Each cell line was cultured in standard
medium as recommended by ATCC. All cells were incubated at 37°C
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injected into the fat pads of C57BL/6 mice. To perform
serial dilution assays, 102, 103, 104, and 105 MDAMB-231 tumor cells were injected s.c. into each dorsal
A
flank. Tumor sizes were measured in perpendicular
P
dimensions using calipers. Volumes were estimated
using the formula (a2 × b)/2, where a is the shorter of
0.814
the 2 dimensions and b is the longer. The P value was
obtained by comparisons between the control and
0.903
treatment groups at each time point. Detailed information on the mice is provided in Supplemental Table 5.
For the metastatic mouse model, 4- to 6-week-old
0.484
female BALB/c mice were injected with MDA-MB-231
cells (5 × 105 in 150 μl PBS) infected with an empty vector, shMYC, or shSLUG into the tail vein. Before being
0.584
euthanized at 5 weeks following injection, all mice
were subjected to a CT scan.
Plasmid constructs and transfection. Plasmids
encoding human MYC (full-length, 1–215, 1–148, 1–95
aa) were generated by PCR amplification and subcloned
0.632
into pcDNA6 expression vectors. Plasmids expressing
the SLUG promoter (–2121–0, –1497–0, –997–0, –496–0,
–200–0 bp) were generated by PCR amplification and
subcloned into pGL3-basic expression vectors. Detailed
information on the plasmid constructs is provided in
Supplemental Table 8. Fidelity of all vectors was confirmed by DNA sequencing. Expression plasmids were
transfected into cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. OE-USP28 was
from Lingqiang Zhang (Beijing Institute of Lifeomics, Beijing, China).
USP28 shRNA expression plasmids and USP28 (C171A) and USP28
deletion constructs were gifts from Binhua P. Zhou (University of Kentucky, College of Medicine, Lexington, Kentucky, USA). LDHA shRNA
expression plasmids and pEGFP-LDHA were provided by Qingkai Yang
(Dalian Medical University, Dalian, China).
Gene knockdown with shRNA. Knockdown of genes was performed
with specific shRNAs delivered using a lentiviral system purchased
from Sigma-Aldrich Corp. according to the instructions provided by
the manufacturer. In brief, to generate the lentivirus containing the
specific shRNA, 293T cells were cotransfected with 2.5 mg pMD2.G
and 7.5 mg psPAX2 compatible packaging plasmids and 10 mg of
pLKO.1 plasmid bearing the specific shRNA for 24 hours. Culture
medium containing the generated lentiviruses was collected and
stored at –80°C as aliquots for further use. To deliver the specific

Table 5. Association of plasma epinephrine level with clinical and pathological
characteristics of breast cancer patients
Variable

All cases N (%)

HER2
<–/+
≥–/+
PR
≤+
≥++
ER
≤+
≥++
Tumor stage
T1
T2
T3
T4
Node stage
N0
N1
N2
N3

Plasma Epi level
Low

High

55 (66.3)
28 (33.7)

29
14

26
14

40 (48.2)
43 (51.8)

21
22

19
21

28 (33.7)
55 (66.3)

13
30

15
25

23 (27.7)
43 (51.8)
13 (15.7)
4 (4.8)

10
24
6
3

13
19
7
1

33 (39.8)
20 (24.1)
19 (22.9)
11 (13.2)

19
11
9
4

14
9
10
7

χ test; n = 83. <–/+, HER2–; ≥–/+, HER2+; ≤+, PR– or ER–; ≥++, PR+ or ER+.

A 2

in a humidified incubator containing 5% CO2. All cell lines are listed in
the Supplemental Table 4.
Chronic stress mouse model. Stressed mice were restrained in a
confined space that prevented them from moving freely or turning
around but did not unduly compress them. This method induces
chronic stress as evidenced by neuroendocrine activation and induction of both anxiety- and depression-like behaviors but does not
cause pain or wounding (5). All mice were subjected to a pretreatment of stress for 7 days to acclimate these conditions for the study.
Then, we inoculated MDA-MB-231 cells (1 × 106) into the pretreated
mice and randomly assigned them to control conditions or daily
restraint stress for a maximum length of 30 days.
Animal studies. Four- to six-week-old NOD/SCID and C57BL/6
mice were used in each experimental group. MDA-MB-231 cells (1 × 106
in PBS/Matrigel [1:1]) were injected s.c. into both flanks of NOD/SCID
mice. E0771 and Py8119 tumor cells (5 × 106 in PBS/Matrigel [1:1]) were

Table 6. Results of multivariate Cox proportional hazards analysis for overall survival and disease-free survival in breast cancer patients
Variable
HER2 <–/+ (vs. ≥–/+)
PR ≤+ (vs. ≥++)
ER ≤+ (vs. ≥++)
Tumor stage T3 + T4 (vs. T1 + T2)
Node stage N2 + N3 (vs. N0 + N1)
Epilo (vs. Epihi)

For OS
Hazard ratio
0.679
0.872
0.886
1.884
1.350
0.322

95% Confidence interval
0.235–1.966
0.326–2.329
0.362–2.168
1.110–3.199
0.883–2.064
0.125–0.828

For DFS
P
0.476
0.785
0.79
0.019
0.165
0.019

Hazard ratio
1.174
1.023
0.953
2.343
1.787
0.171

95% Confidence interval
0.437–3.150
0.410–2.553
0.411–2.209
1.415–3.882
1.188–2.689
0.063–0.465

P
0.751
0.961
0.910
0.01
0.05
0.01

n = 83. OS, overall survival; DFS, disease-free survival. <–/+ , HER2–; ≥–/+, HER2+; ≤+,PR– or ER–; “≥++, PR+ or ER+.
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shRNA construct, approximately 10% confluent cells were infected
with lentiviruses bearing the specific shRNA in growth medium containing 8 mg/ml Polybrene and were incubated at 37°C for 24 hours.
Transfected cells were subsequently selected with 2 mg/ml puromycin
at approximately 50% confluence. Details on the shRNAs are provided
in Supplemental Table 7.
Quantitative reverse transcriptase PCR. Total RNA was extracted
using TRIzol reagent (Invitrogen) and used to generate cDNA by
EasyScript One-Step gDNA Removal and cDNA Synthesis SuperMix
(TransGen Biotech) with an oligo-dT primer. Real-time reverse transcriptase PCR was performed using SYBR Select Master Mix (Life
Technologies) as recommended by the manufacturer. ACTB was used
as the internal control. All primers are listed in Supplemental Table 6.
Immunoprecipitation and immunoblot assays. Cells were treated
with the proteasome inhibitor MG132 (10 μM) for 6 hours before cell
lysis. Coimmunoprecipitation was performed using 1 μg of antibodies and 200–500 μg of exogenous protein lysates. Protein A/G PLUSAgarose immunoprecipitation reagent was then added, and this incubation was continued for 8 hours at 4°C. Beads were washed 3 times with
1 ml of coimmunoprecipitation buffer and subjected to Western blot
analysis. Cells were lysed on ice in RIPA buffer, and protein concentrations were determined using Coomassie Brilliant Blue. Equal amounts
of protein were subjected to electrophoresis on 10% gradient SDSPAGE gels followed by immunoblot assays with the antibodies listed in
Supplemental Table 1. See Supplemental data for the unedited blots.
Luciferase reporter assay. Cells were plated at a density of 1 × 105 cells
per well in 24-well plates. After 20 hours, cells were transfected with SLUG
promoter–driven luciferase constructs (pGL3-SLUG) or control (pGL3Basic) luciferase constructs. Fluc/Rluc activities were measured using
the Dual Luciferase Reporter Assay System (Promega). Information on the
Critical Commercial Assays is provided in Supplemental Table 3.
Mammosphere culture. Sphere formation was performed in
ultralow attachment plates (Corning) with medium supplemented
with 2% B27, 20 ng/ml bFGF, and 20 ng/ml EGF. MDA-MB-231 and
MCF-7 cells were seeded at a density of around 2 cells/μl and cultured
at 37°C with 5% CO2. After 14 days, spheres greater than 50 μm diameter were counted at ×40 magnification (Olympus). The reagents used
are listed in Supplemental Table 2.
Chromatin immunoprecipitation. ChIP was performed using
ChIP-IT Express Chromatin Immunoprecipitation Kits (Active Motif)
according to the manufacturer’s protocol. See Supplemental Methods
for details. Detailed information on the Critical Commercial Assays
is provided Supplemental Table 3, and the primers used are listed in
Supplemental Table 6.
Immunohistochemical staining and statistical analysis. Paraffinembedded tissue blocks were used for immunohistochemical staining. Paraffin-embedded tissue specimens were sectioned, deparaffinized in xylene, and rehydrated, followed by antigen retrieval in sodium
citrate, and the sections were then processed using SPlink Detection
Kits (ZSGB-BIO) according to the manufacturer’s instructions. The
sections were incubated with primary antibodies (1:200 dilution)
overnight at 4°C. Specimens were stained using a DAB kit (ZSGB-BIO)
until the desired stain intensity was developed. Sections were then
counterstained with hematoxylin, dehydrated, and mounted. Staining
intensity and extent of staining were graded as follows: negative (score
0), bordering (score 1), weak (score 2), moderate (score 3), and strong
(score 4). Extent of staining was also grouped into quantiles accord1044
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ing to the percentage of high-staining cells per field: negative (score
0), 25% (score 1), 26%–50% (score 2), 51%–75% (score 3), and 76%–
100% (score 4). All immunohistochemical staining was evaluated and
scored by at least 2 independent pathologists. Details on the Critical
Commercial Assays are provided in Supplemental Table 3.
Pharmacological studies. Cells were maintained in DMEM for 8–12
hours that was followed by DMEM supplemented with 2% FBS for 5
days with different pharmaceutical treatments. The concentration
of all drugs was chosen based on successful activation/inhibition in
previous publications: epinephrine (10 nM), propranolol (10 μM), and
ICI118,551 (10 μM). For other drugs, cells were maintained in 10%
DMEM: vitamin C (1 μM), actinomycin D (5 μg/ml), cycloheximide
(200 μg/ml). For mice, epinephrine (2 mg/kg/d, s.c.), propranolol (2
mg/kg/d, i.p.), and ICI118,551 (25 μM/100 μl, i.p.) were injected 7
days before tumor cell injection. The control group of mice received
an equal volume of PBS. Detailed information on the chemicals used
are listed in Supplemental Table 2.
Metabolic assays. Glucose uptake, lactate production, and ATP concentrations were measured by assay kits from BioVision. All procedures
were performed as recommended by the manufacturer. Information
on the Critical Commercial Assays is provided in Supplemental Table 3.
Metabolomics analysis. Cells were washed with 10 ml mannitol 3
times. This was followed by addition of 1 ml methanol containing 10
μM of d-camphor-10-sulfonic acid sodium salt as internal standards
to each plate. Cells were then scraped (Corning) and transferred to a
5-ml Eppendorf tube. One milliliter of chloroform was then added to
the tube, followed by vortexing for 30 seconds. Water in the amount of
400 μl was subsequently added to form a 2-phase system. After vortexing for 1 minute, the mixture was left to stand for 5 minutes and
then centrifuged at 15,000 g for 15 minutes at 4°C. Subsequently, 450
μl of the upper layer was transferred and was filtered via centrifugation through a 5-kDa-cutoff filter (Millipore) to remove proteins (9100
g, 3 hours at 4°C). The filtrate was lyophilized and stored at –80°C.
Before CE-TOF/MS analysis, dried samples were reconstituted in
Milli-Q water (MilliporeSigma) containing 50 μM of trimesic acid and
2-naphtol-3,6-disulfonic acid disodium salt as internal standards to
adjust for migration time in the anion mode.
Screening of US drug collection of compounds against LDHA. MDAMB-231 cells were stably infected with LDHA that was subcloned
into the pEGFP-C1 vector and then plated onto 96-well plates. Individual drugs were added to each well for 6 (1 μM, T1; or 2 μM, T2)
and 12 hours (1 μM, T3) at 50% confluence. After washing of cells
with PBS, LDHA expression in infected cells was determined by fluorescence detection.
In vitro limiting dilution assay. Limiting dilution assay was performed as described previously (70). Briefly, dissociated primary cells
were seeded in 96-well plates at densities of 1, 2, 4, 8, 16, 32, and 64 cells
per well. Wells with no sphere were counted for each group after 7 days.
Statistics. Each in vivo and in vitro experiment was performed in
triplicate and repeated at least 3 times. Statistical analyses were performed with SPSS software (version 16.0) or GraphPad Prism 6.0
(GraphPad Software Inc.). Differences between variables were assessed
by 2-tailed Student’s t test, 1-way ANOVA, and χ2 test, where appropriate. Data were expressed as mean ± SEM. P values less than 0.05 were
considered statistically significant (*P < 0.05, **P < 0.01, ***P < 0.001).
Accession number. The mRNA array data were deposited in the
GEO database with accession number GSE116781.
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Study approval. All animals were housed and handled in accordance with the Animal Care and Use Committee at Dalian Medical
University. All animal studies were conducted in accordance with the
Dalian Medical University guidelines for animal care, and all animal
procedures were approved by the IACUC of the Dalian Medical University (Dalian, China). All studies were performed in accordance
with national animal protection laws (certificate number AEE18018).
All studies involving patients’ samples were approved by the IRBs of
the Cancer Center of Sun Yat-sen University, with informed consent.
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